ArticleVaccines2026

Estimating and Projecting Efficacy of Monoclonal Antibodies Against Respiratory Syncytial Virus Beyond Clinical Trial Periods.

Dawei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.